🔗 Share this article

A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users administering substances of uncertain source.

Some professionals stated the popularity for retatrutide could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or prison.

Platform Reaction and Content Removal

Based on TikTok, the service has removed problematic content and prohibited associated hashtags and query recommendations. The company said it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with numerous of users, populated with photos of weight loss, positive testimonials and detailed instructions for mixing or injecting at residence.

Within moments of entering one community, a seller shared WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Costs

Inside these groups, messages display dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how long a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these digital versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose users to potentially significant health risks”.